Co-Diagnostics, Inc. (CODX)
USD 0.32
(-9.78%)
USD 0.32
(-9.78%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -42.7 Million USD | -318.65% |
| 2022 | -11.59 Million USD | -125.16% |
| 2021 | 46.06 Million USD | 10.48% |
| 2020 | 41.69 Million USD | 807.42% |
| 2019 | -5.89 Million USD | 3.66% |
| 2018 | -6.11 Million USD | -34.04% |
| 2017 | -4.56 Million USD | -170.39% |
| 2016 | -1.68 Million USD | 14.23% |
| 2015 | -1.96 Million USD | -90.26% |
| 2014 | -1.03 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -10.17 Million USD | 2.85% |
| 2024 Q1 | -10.47 Million USD | 11.42% |
| 2023 FY | -48.52 Million USD | -318.65% |
| 2023 Q1 | -9.95 Million USD | -359.43% |
| 2023 Q2 | -11.99 Million USD | -20.54% |
| 2023 Q3 | -8.93 Million USD | 25.5% |
| 2023 Q4 | -11.82 Million USD | -32.33% |
| 2022 Q2 | -4.14 Million USD | -163.43% |
| 2022 FY | -11.59 Million USD | -125.16% |
| 2022 Q4 | 3.83 Million USD | 158.69% |
| 2022 Q3 | -6.53 Million USD | -57.6% |
| 2022 Q1 | 6.53 Million USD | -36.58% |
| 2021 Q1 | 10.33 Million USD | -35.52% |
| 2021 FY | 46.06 Million USD | 10.48% |
| 2021 Q4 | 10.3 Million USD | -24.37% |
| 2021 Q3 | 13.63 Million USD | 15.6% |
| 2021 Q2 | 11.79 Million USD | 14.09% |
| 2020 Q3 | 12.03 Million USD | -2.44% |
| 2020 FY | 41.69 Million USD | 807.42% |
| 2020 Q4 | 16.02 Million USD | 33.15% |
| 2020 Q2 | 12.33 Million USD | 1240.43% |
| 2020 Q1 | -1.08 Million USD | 33.35% |
| 2019 Q1 | -1.25 Million USD | 31.19% |
| 2019 Q4 | -1.62 Million USD | 1.62% |
| 2019 Q2 | -1.36 Million USD | -8.87% |
| 2019 Q3 | -1.65 Million USD | -20.82% |
| 2019 FY | -5.89 Million USD | 3.66% |
| 2018 Q3 | -1.66 Million USD | -22.94% |
| 2018 FY | -6.11 Million USD | -34.04% |
| 2018 Q1 | -1.27 Million USD | 14.48% |
| 2018 Q2 | -1.35 Million USD | -5.94% |
| 2018 Q4 | -1.82 Million USD | -9.59% |
| 2017 Q4 | -1.49 Million USD | 17.25% |
| 2017 Q1 | -564.36 Thousand USD | -26.94% |
| 2017 FY | -4.56 Million USD | -170.39% |
| 2017 Q3 | -1.8 Million USD | -157.52% |
| 2017 Q2 | -700.95 Thousand USD | -24.2% |
| 2016 Q3 | -392.35 Thousand USD | -0.53% |
| 2016 Q1 | -460.74 Thousand USD | -2.52% |
| 2016 FY | -1.68 Million USD | 14.23% |
| 2016 Q4 | -444.57 Thousand USD | -13.31% |
| 2016 Q2 | -390.29 Thousand USD | 15.29% |
| 2015 FY | -1.96 Million USD | -90.26% |
| 2015 Q4 | -449.4 Thousand USD | 0.0% |
| 2014 FY | -1.03 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -197.376% |
| Cerus Corporation | -30.05 Million USD | -42.103% |
| OrthoPediatrics Corp. | -25.76 Million USD | -65.746% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -302.08% |
| Talis Biomedical Corporation | -66.81 Million USD | 36.083% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -146.914% |
| Inogen, Inc. | -109.38 Million USD | 60.958% |
| Spectral AI, Inc. | -12.98 Million USD | -228.914% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 31.767% |
| CVRx, Inc. | -43.1 Million USD | 0.921% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1110.494% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -243.629% |
| Orthofix Medical Inc. | -139.11 Million USD | 69.3% |
| Venus Concept Inc. | -28.3 Million USD | -50.857% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 20.955% |
| Bioventus Inc. | -81.72 Million USD | 47.744% |
| BrainsWay Ltd. | -4.92 Million USD | -766.78% |
| Envoy Medical, Inc. | -18.37 Million USD | -132.465% |
| electroCore, Inc. | -18.8 Million USD | -127.1% |
| IceCure Medical Ltd | -15.57 Million USD | -174.18% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 11.913% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -147.314% |
| MaxCyte, Inc. | -48.29 Million USD | 11.579% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -257.217% |
| Nexalin Technology, Inc. | -5.69 Million USD | -649.719% |
| PAVmed Inc | -68.79 Million USD | 37.922% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 24.498% |
| RxSight, Inc. | -50.08 Million USD | 14.732% |
| Sight Sciences, Inc. | -57.27 Million USD | 25.435% |
| SI-BONE, Inc. | -46.93 Million USD | 9.002% |
| TELA Bio, Inc. | -44.07 Million USD | 3.106% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 21.133% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 16.959% |
| LivaNova PLC | -68.49 Million USD | 37.653% |
| 908 Devices Inc. | -42.75 Million USD | 0.121% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 75.371% |
| Nemaura Medical Inc. | -9.59 Million USD | -345.078% |
| NeuroPace, Inc. | -27.17 Million USD | -57.158% |
| LENSAR, Inc. | -12.22 Million USD | -249.221% |
| Apyx Medical Corporation | -17.25 Million USD | -147.443% |
| Cutera, Inc. | -156.23 Million USD | 72.665% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -396.353% |
| BioSig Technologies, Inc. | -28.51 Million USD | -49.783% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 51.27% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -90.262% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 138.293% |
| Axonics, Inc. | -26.05 Million USD | -63.895% |
| Outset Medical, Inc. | -169.77 Million USD | 74.845% |
| IRIDEX Corporation | -10 Million USD | -326.764% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 60.881% |
| IRadimed Corporation | 20.03 Million USD | 313.153% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -417.965% |
| INVO Bioscience, Inc. | -6.76 Million USD | -531.081% |
| Telesis Bio, Inc. | -35.15 Million USD | -21.497% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 398.02% |
| Varex Imaging Corporation | 32.1 Million USD | 233.041% |
| Quipt Home Medical Corp. | 3.91 Million USD | 1189.723% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -251.984% |
| Pulmonx Corporation | -61.93 Million USD | 31.047% |
| Dynatronics Corporation | -2.27 Million USD | -1778.809% |
| Modular Medical, Inc. | -17.52 Million USD | -143.632% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -191.729% |
| Semler Scientific, Inc. | 22.25 Million USD | 291.886% |
| InMode Ltd. | 195.66 Million USD | 121.827% |
| Bruker Corporation | 436.9 Million USD | 109.775% |
| Cytosorbents Corporation | -31.2 Million USD | -36.838% |
| DexCom, Inc. | 597.7 Million USD | 107.145% |
| Align Technology, Inc. | 643.33 Million USD | 106.638% |
| Viveve Medical, Inc. | -21.55 Million USD | -98.145% |
| ZimVie Inc. | -30.93 Million USD | -38.034% |
| Movano Inc. | -29.69 Million USD | -43.84% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -53.371% |
| Nexalin Technology, Inc. | -5.69 Million USD | -649.719% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1110.494% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 81.689% |
| Profound Medical Corp. | -28.61 Million USD | -49.239% |
| Insulet Corporation | 220 Million USD | 119.412% |
| enVVeno Medical Corporation | -25.23 Million USD | -69.214% |
| Surmodics, Inc. | -5.64 Million USD | -656.532% |
| iCAD, Inc. | -7.68 Million USD | -455.42% |
| Nuwellis, Inc. | -17.63 Million USD | -142.236% |
| Biotricity, Inc. | -8.82 Million USD | -383.744% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 65.879% |
| Aethlon Medical, Inc. | -12.63 Million USD | -237.958% |
| InspireMD, Inc. | -21.14 Million USD | -101.988% |
| PAVmed Inc. | -68.79 Million USD | 37.922% |
| BIOLASE, Inc. | -17.93 Million USD | -138.09% |
| Beyond Air, Inc. | -63 Million USD | 32.219% |
| FONAR Corporation | 16.53 Million USD | 358.272% |
| AxoGen, Inc. | -21.46 Million USD | -98.985% |
| Vivani Medical, Inc. | -26.96 Million USD | -58.377% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 336.718% |
| Inari Medical, Inc. | -14.03 Million USD | -204.349% |
| UFP Technologies, Inc. | 57.66 Million USD | 174.06% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -766.674% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -577.256% |
| Tenon Medical, Inc. | -15.72 Million USD | -171.547% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -471.397% |
| AdaptHealth Corp. | -598.4 Million USD | 92.863% |
| Sintx Technologies, Inc. | -13.35 Million USD | -219.705% |
| NanoVibronix, Inc. | -3.43 Million USD | -1142.906% |
| Quanterix Corporation | -49.7 Million USD | 14.074% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -251.984% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -11079.642% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 87.232% |
| TransMedics Group, Inc. | -28.72 Million USD | -48.662% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -80.867% |
| NeuroMetrix, Inc. | -7.15 Million USD | -497.163% |
| Hyperfine, Inc. | -48.11 Million USD | 11.241% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 34.324% |
| Biomerica, Inc. | -6.36 Million USD | -570.743% |
| Bone Biologics Corporation | -9.42 Million USD | -352.958% |
| AVITA Medical, Inc. | -40.4 Million USD | -5.703% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -314.173% |
| Silk Road Medical, Inc | -59.27 Million USD | 27.948% |